Abstract
Objective To investigate the provision of pharmaceutical care by community pharmacists across Europe and to examine the various factors that could affect its implementation. Methods A questionnaire-based survey of community pharmacies was conducted within 13 European countries. The questionnaire consisted of two sections. The first section focussed on demographic data and services provided in the pharmacy. The second section was a slightly adapted version of the Behavioral Pharmaceutical Care Scale (BPCS) which consists of three main dimensions (direct patient care activities, referral and consultation activities and instrumental activities). Results Response rates ranged from 10–71% between countries. The mean total score achieved by community pharmacists, expressed as a percentage of the total score achievable, ranged from 31.6 (Denmark) to 52.2% (Ireland). Even though different aspects of pharmaceutical care were implemented to different extents across Europe, it was noted that the lowest scores were consistently achieved in the direct patient care dimension (particularly those related to documentation, patient assessment and implementation of therapeutic objectives and monitoring plans) followed by performance evaluation and evaluation of patient satisfaction. Pharmacists who dispensed higher daily numbers of prescriptions in Ireland, Germany and Switzerland had significantly higher total BPCS scores. In addition, pharmacists in England and Ireland who were supported in their place of work by other pharmacists scored significantly higher on referral and consultation and had a higher overall provision of pharmaceutical care. Conclusion The present findings suggest that the provision of pharmaceutical care in community pharmacy is still limited within Europe. Pharmacists were routinely engaged in general activities such as patient record screening but were infrequently involved in patient centred professional activities such as the implementation of therapeutic objectives and monitoring plans, or in self-evaluation of performance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.
Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP. 1990;24:1093–7.
Rovers PR, Currie JD, Hagel HP, McDonough RP, Sobotka JL. A practical guide to pharmaceutical care. Washington: The American Pharmaceutical Association; 1998.
Odedina FT, Segal R. Behavioral pharmaceutical care scale for measuring pharmacists’ activities. Am J Health Syst Pharm. 1996;53:855–65.
Penna RP. Pharmaceutical care: pharmacy’s mission for the 1990 s. Am J Hosp Pharm. 1990;47:543–9.
Bagozzi RP. The self-regulation of attitudes, intentions, and behavior. Soc Psychol Q. 1992;55:178–204.
Raisch DW. Barriers to providing cognitive services. Am Pharm. 1993;NS33:54–8.
Reutzel TJ. The compatibility of the retail setting with a patient-based practice model: Reports from community pharmacists. J Clin Pharm Ther. 1994;19:301–12.
Elnour AA, El Mugammar IT, Jaber T, Revel T, McElnay JC. Pharmaceutical care of patients with gestational diabetes mellitus. J Eval Clin Pract. 2008;14:131–40.
Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. Int J Pharm Pract. 2005;13:53–70.
Lambert BL. Face and politeness in pharmacist-physician interaction. Soc Sci Med. 1996;43:1189–98.
Rossing C, Hansen EH, Krass I. The provision of pharmaceutical care in Denmark: a cross-sectional survey. J Clin Pharm Ther. 2003;28:311–8.
Bell HM, McElnay JC, Hughes CM, Woods A. Provision of pharmaceutical care by community pharmacists in Northern Ireland. Am J Health Syst Pharm. 1998;55:2009–13.
Robinson JP, Shaver PR, Wrightsman LS. Criteria for scale selection and evaluation. In: Robinson JP, Shaver PR, Wrightsman LS, editors. Measures of personality and social psychological attitudes, vol. 1. San Diego: Academic Press; 1991. p. 1–15.
Costello AB, Osborne W. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval. 2005;10:1–9.
Kaiser HF. An index of factorial simplicity. Pschometrika. 1974;39:31–6.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw Hill Higher Education; 1998.
Odedina FT, Segal R, Hepler CD. Providing pharmaceutical care in community practice: differences between providers and non-providers of pharmaceutical care. J Soc Admin Pharm. 1995;12:170–80.
Harris WE, Rivers PH, Goldstein R. The potential role of community pharmacists in care management. Health Soc Care Commun. 1998;6:196–203.
van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.
Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: Practice and research from around the world. Ann Pharmacother. 2005;39:1539–41.
Fowler FJ. Survey research methods. 3rd ed. London: Sage Publications; 2002.
Conflicts of interest statement
None declared.
Funding
All national studies were funded locally by the researchers. Coordination of the studies was not funded separately.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hughes, C.M., Hawwa, A.F., Scullin, C. et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci 32, 472–487 (2010). https://doi.org/10.1007/s11096-010-9393-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-010-9393-x